The mouse coat color mutant mahoganoid (md) darkens coat color and decreases the obesity of A y mice that ectopically overexpress agouti-signaling protein. The phenotypic effects of md are similar to those of the recently identified coat color mutant mahogany (Atrn mg ). We report the positional cloning of mahoganoid, encoding a novel 494-amino acid protein containing a C3HC4 RING (really interesting new gene) domain that may function as an E3 ubiquitin ligase. The mutations in the mahoganoid allelic series (md, md 2J , md 5J ) are all due to large retroviral insertions. In md and md 2J , the result is minimal expression of the normal size transcripts in all tissues examined. Unlike Atrn mg/ Atrn mg animals, we observe no evidence of neurological deficit or neuropathology in md/md mice. Body weight and body mass index (a surrogate for adiposity) measurements of B6.C3H-md-A md/+ and md/md animals on 9% and 45% kcal fat diets indicate that mahoganoid does not suppress body weight in B6.C3H animals in a gene dose-dependent fashion. Mahoganoid effects on energy homeostasis are, therefore, most evident in the circumstances of epistasis to hypothalamic overexpression of ASP in A y and possibly other obesity-causing mutations.
Introduction
Molecular cloning of the five extant monogenic forms of rodent obesity identified critical molecules in the pathways regulating energy homeostasis in animals and humans (1) . The agouti (A) gene encodes a 131-amino acid peptide agouti-signaling protein (ASP) that is normally secreted only in the follicular cells of the dermal papilla of the skin (2) (3) (4) . Mutations of agouti (e.g., A y and A vy ) that cause ectopic overexpression of ASP in the hypothalamus and skin result in a pleiotropic syndrome that includes increased lean and adipose tissue, yellow pelage (coat), hyperinsulinemia, hyperphagia, and hyperglycemia (3) (4) (5) . ASP antagonizes the binding of α-melanocortin stimulating hormone (α-MSH) to the melanocortin 1 receptor (MC1R), causing melanogenesis to switch from the production of black/brown pigment (eumelanin) to a yellow/red pigment (pheomelanin) (see Figure 1 ) (2) . In the hypothalamus, agouti-related protein (AgRP) is the natural antagonist of MC3R and MC4R. AgRP also acts as an inverse agonist at MC4R in both the human and mouse (6, 7) . In A y mice, ectopically produced ASP competes with α-MSH for binding to MC3R and MC4R, resulting in hyperphagia, increased body fat, and disordered insulin homeostasis (8) .
Two other mutations, mahogany (Atrn mg , Chr 2) and mahoganoid (md, Chr 16), affect coat color and body weight. Both mutations are unique in their ability to suppress the obesity and darken the coat (umbrous effect) caused by mutations resulting in the ectopic overexpression of ASP. There are three reported alleles of mahogany, Atrn mg , Atrn mg-L , and Atrn mg-3J , that are coisogenic on mouse strains LDJ/Le, C3H/HeJ, and C3HeB/FeJ, respectively (9, 10) . Atrn mg and Atrn mg-L are each the result of approximately 5 kb retrovirus insertions in introns 26 and 27, respectively, that disrupt the splicing of Atrn. Atrn mg-3J has a 5-bp deletion at nucleotide 2,809, introducing a stop codon that results in a severely truncated protein. Attractin (Atrn) encodes a single-pass transmembrane, approximately 210-kDa protein containing three EGF domains, two lamininlike EGF repeats, a CUB domain, two plexinlike repeats, a C-type lectin, and seven consecutive Kelch repeats (9, 10) . The predicted structure of ATTRACTIN protein suggests that it functions as a receptor or receptor-like protein. The Atrn mg mutation does not suppress the obese phenotype of Mc4r-null mice or that of several monogenic obese models (Lepr db , Lep ob , tub, Cpe fat ) (9, 10) , but does suppress diet-induced obesity (10) . Homozygosity for LDJ/Le Atrn mg backcrossed for six to eight generations onto a C57BL/6J background suppresses A y -induced weight gain by increasing basal metabolic rate (11) . In animals doubly mutant for mg and A y , food intake is not reduced relative to controls (homozygous wild-type Ay/a and mg/mg a/a), but body weight is reduced due to higher metabolic rate (11) . Mahogany mice are not hyperphagic on a C3H/HeJ background (12) . Homozygous Atrn mg animals develop abnormal myelination and vacuolization throughout the brain and spinal cord in association with severe tremors and flaccid paresis (13) . The tremors may account for the increased metabolic rate. The neuropathological changes characteristic of Atrn mg animals and the specificity of binding of ASP but not AgRP to ATRN (14) make it unlikely that ATRN plays a specific role in hypothalamic control of energy homeostasis, aside from its effects on muscle motor activity.
Md has effects on coat color and obesity in A y mice that are analogous to Atrn mg . The md mutation originally arose spontaneously in the C3H/HeJ strain at The Jackson Laboratory (Bar Harbor, Maine, USA) in the early 1960s. Subsequently, four additional spontaneous mutations (md 2J , md 4J , md 5J , and md 6J ) have been documented at this locus (http://www.informatics.jax.org/searches/allele_report.cgi? _Marker_key=11177). Like Atrn mg , mahoganoid darkens the back, ears, and tail of nonalbino mice (15, 16) . This darkening effect is described as an "umbrous" coat. Md suppresses A y -induced yellow pigmentation and A y -induced obesity in a gene dosedependent manner (17) . Similar to Atrn mg on the C57BL/6J background, homozygosity for md on the C3H/HeJ background causes hyperphagia (11) . The ability of md to induce hyperphagia suggests that the md gene product has effects on energy homeostasis distinct from epistatic effects in the context of overexpression of ASP (A y ). Genetic studies have positioned md, functionally, at the same level or upstream of MC1R and downstream of ASP based on findings that the Mc1r e mutation (extension, resulting in a yellow coat) suppressed the coat color effect of md and that md suppressed both the yellow and obese phenotypes of A y mice (17) (Figure 1 ). Linkage analysis positioned md on chromosome 16, about 2 cM from the centromere (18, 19) . Identification of md and its function could provide additional insight into the control of melanocortin signaling. Here we report the positional cloning of the mouse mahoganoid through a combination of genetic mapping and bioinformatic approaches.
Methods
Animals. N 7 F 14 B6.C3H-md-A (md/md and md/+) mice were obtained from The Jackson Laboratory. The coat color effect of the mutation is easiest to detect on an agouti (A) coat (Figure 2 ), hence these animals have been selected and bred for phenotypes at two loci on different chromosomes (md and A). Progeny for genetic mapping of the region around md were generated by mating md/md A/? × md/+ A/? animals of this congenic strain. The fact that this line was maintained by coat color selection offered the opportunity to map and reduce by meiotic recombination the C3H genetic interval containing the md locus. Mice were housed in a barrier facility under pathogen-free conditions with a 12-hour light/dark cycle. Mice were weaned at 21 days and were then given ad libitum access to 9% kcal fat Picolab Rodent Chow 20 (Purina Mills Inc., Richmond, Indiana, USA) or to 45% kcal fat D12451 (Research Diets Inc., New Brunswick, New Jersey, USA). Mice were fasted for 2 hours prior to sacrifice by CO 2 
Figure 1
Schematic of melanocortin-signaling pathways, specifically melanocortin signaling in the hair follicle and hypothalamus. α-MSH is a melanocortin peptide that is cleaved from the proopiomelanocortin precursor (POMC). (a) α-MSH acts on MC1R, resulting in an increase in cAMP to darken coat color. ASP antagonizes α-MSH binding at MC1R, resulting in pheomelanin synthesis. ATRN (mahogany) may function to downregulate or desensitize MC1R or may be involved in ASP processing or binding to MC1R. (b) α-MSH activates MC4R to decrease food intake and increase energy expenditure. AgRP competes with α-MSH for binding at MC4R/MC3R, resulting in increased food intake. A y mice ectopically overproduce ASP, interfering with α-MSH signaling at MC4R/MC3R and resulting in an obese phenotype due to increased food intake.
B6.C3H-md/+ A/? cross were used for genetic mapping of mahoganoid. Homozygosity for md was scored by observation of coat color (Figure 2 Mouse genomic clones were used to search these databases to construct a complete 2.5-Mb contig of mouse bacterial artificial chromosome clones (http://genomics.roswellpark.org/cgibin/mouse/markers.cgi?chr = 16) spanning the minimal interval containing md. All transcripts in the interval were identified using Celera (Rockville, Maryland, USA) and National Center for Biotechnology (NCBI; Bethesda, Maryland, USA) databases.
Sequence analysis of positional candidate genes. To screen for mutations in the coding sequences of the transcripts and predicted genes mapping to the minimal contig, each of the exons was amplified from genomic DNA by PCR followed by amplicon purification by QIAquick Gel Extraction Kit (QIAGEN Inc.) and bidirectional fluorescent dideoxy termination sequencing (20) . This process was prioritized so that the known transcripts were screened before the predicted genes. Sequences from C3H/HeJ +/+ and C3H/HeJ md 2J /md 2J (coisogenic on C3H/HeJ) were compared using Sequencher software 4.0.5 (Gene Codes Corp., Ann Arbor, Michigan, USA).
Southern blot analysis. Genomic DNA of affected md, md 2J , md 4J , md 5J , and md 6J obtained from The Jackson Laboratory was analyzed by Southern blot analysis (21) using restriction enzymes PstI, EcoRI, HindIII, Sau3AI, MspI, and BglII (Roche Diagnostics Corporation, Indianapolis, Indiana, USA). Restriction fragments were separated by electrophoresis on 0.7% agarose gels, transferred by capillary action to a nylon membrane (Schleicher & Schuell Inc., Keene, New Hampshire, USA), prehybridized (Ultrahyb; Ambion Inc., Woodward, Texas, USA), and hybridized using a random-primed 32 P-labeled C3H/HeJ genomic PCR-amplified fragment prepared using the following primers: probe 1, F: 5′-GATGGGGCTTGAGTCCT-TAGA-3′, R: 5′-CCTCAGCCCAGCACTTT-CTCT-3′, flanking exon 12 of Riken fulllength cDNA AK011747 (shown by mutation analysis to contain the md gene, see below); and probe 2, F: 5′-GGCAGGTGGGAACAGATGAGT-3′, R: 5′-CCGTCCGAGATGCCTGAGTAG-3′, spanning the intronic region between exon 11 and exon 12. Two cDNA probes (probes 3 and 4) spanning, respectively, exons 2-9 and exons 3-13 of AK011747, were prepared from pooled C57BL/6J cDNA obtained from liver, kidneys, lungs, spleen, brain, adipose, pancreas, and heart cDNA using the following primers: probe 3, F: 5′-TTGACACTCCC-CATCCTGAAG-3′, R: 5′-TCCTGGTTGTT-CTTGTTCTCG, and probe 4, F: 5′-CCAG-TTTCCCTATGTCACCCC-3′, R: 5′-ATGG-ATGGGGAATGATGGAGA-3′. The blots were washed in 1× SSC/0.1% SDS twice for 10 minutes at room temperature and twice for 30 minutes at 64°C and exposed to x-ray film (RX-B; Denville, Metuchen, New Jersey, USA) at -80°C for 48 hours.
Northern blot analysis. Northern blots of liver, heart, kidney, lung, skin, skeletal muscle, adipose, and brain tissue were performed using standard techniques (21) . Total RNA was extracted using a commercial kit (Trizol; Invitrogen Corp., Carlsbad, California, USA) and size fractionated on a 1% agarose formaldehyde gel. Blot handling was as for Southern blots. Only probe 4 was used for Northern hybridizations.
Real time RT-PCR. RNA was extracted from flash-frozen, freshly dissected whole organs using a commercial kit (Trizol; Invitrogen Corp.) and purified using RNeasy Mini kits (QIAGEN Inc.). cDNA was then made using SuperScript First-Strand Synthesis System for RT-PCR (Invitrogen Corp.) with 50 ng of random hexamers for each microgram of total RNA. A negative control for cDNA was made in an identical manner without adding the SuperScript II RT to each tube. The cDNA was diluted fivefold prior to use. A LightCycler (Roche Molecular Biochemicals, Mannheim, Germany) was used to quantify expression levels with 20-µl reactions consisting of 2 µl diluted cDNA, 16 µl FastStart DNA Master SYBR Green I mix (Roche Molecular Biochemicals), and 2 µl of primers (F: 5′-TGTCTCC-CATCTCCTTCAGCC-3′; R: 5′-CTGT-GTCTTGCCCTTCTGTAG-3′) spanning exon 11-12 of Riken cDNA AK011747. Each sample was run in triplicate with one negative control. β-actin (F: 5′-ATCGCTGCGCTGGTC-GTC-3′; R: 5′-GCTCTGGGCCTCGTCA-CC-3′) was used to normalize expression levels. Only one product was seen on the melting curves, so fluorescent acquisition was set at the extension stage. Relative expression levels were found by comparing expression levels in each organ to the level found in homozygous wild-type C57BL/6J mice in the same organ (22) . PCR fragments were resolved on 2% agarose gel.
Generating restriction maps of md GENOMIC sequence. Ensembl gene ENSMUSG00000022517, containing the complete genomic sequence of md, was identified through nBlast of transcript AK011747 into genomic DNA database Ensembl (Ensembl, Cambridge, United Kingdom). The genomic sequence obtained was used as a control template in creating the restriction map for the md. Sequencher software 4.0.5 (Gene Codes Corp.) was used on both the normal and inserted retroviral sequences to determine the restriction sites and fragment sizes for specific restriction enzymes.
Neuropathology. Fifteen-week-old C3H.B6 md/md A/? and C57BL/6J +/+ male and female mice were sacrifice by
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Results
By genotyping congenic B6.C3H-md/md A/? mice for microsatellite genetic markers polymorphic between C57BL/6J and C3H/HeJ, the maximal congenic C3H/HeJ interval was determined to extend approximately 6.9 cM from the centromere to D16Mit181 (Figure 3 ). (Figure 3) .
Using sequence databases at NCBI, Celera, Ensembl, The Jackson Laboratory, and University of California, Santa Cruz (see Methods for URL information), all mouse genomic clones in the 2.5-Mb interval containing md proximal to D16Mit129 and D16Mit54 were identified ( Figure 4 ). Twenty-nine transcripts and 39 computationally predicted genes (24) were identified. Using nBlast, transcripts were compared against the Ensembl mouse cDNA database to obtain genomic sequences with exon predictions. These genes were then systematically analyzed as indicated below. The coding regions of 27 of the 29 known transcripts, excluding X94084 and AK004765, were systematically sequenced in md 2J and coisogenic C3H/HeJ +/+ animals. By virtue of the disruptions described below in md 2J and other members of the mahoganoid allelic series, Riken cDNA AK011747 was implicated as the mahoganoid transcript.
md 2J , an 8 kb retroviral insertion within exon 12. Each of the predicted coding sequences of ESTs, known genes, and computationally predicted genes in the minimum physical interval for mahoganoid were amplified from genomic DNA of an md 2J /md 2J mouse and a coisogenic nonmutant animal using intronic primers flanking the known or predicted exons in the interval. For the Riken cDNA clone AK011747, all exons except exon 12 were amplified from both the md 2J /md 2J and C3H/HeJ +/+ mice. For exon 12, the normal 589 bp C3H/HeJ allele could be amplified in the homozygous wild-type as well as all of the md alleles except md 2J (Figure 5a ). PCR amplification and subsequent bidirectional sequencing of predicted coding exons 2-16 from homozygous affected md, md 2J , md 4J , md 5J , and md 6J mice demonstrated normal genomic sequence. Southern blot analysis of md 2J /md 2J animals restricted with PstI, using probe 2, which contained part of exon 12 and its 5′ intronic region, showed a novel 0.7 kb fragment in the md 2J /md 2J animal compared with a 1.4 4J , md 5J , md 6J ) genomic DNA probed with part of exon 12 and its 5′ intronic region. The md 2J revealed a new fragment of 0.7 kb and a lack of fragment of 1.4 kb corresponding to exon 12, whereas md showed a loss of a 1.1 kb fragment and a novel 0.6 kb fragment corresponding to the intronic region 5′ of exon 12. md 4J , md 5J , and md 6J showed fragments of similar size to the C3H/HeJ +/+ control. (c) Southern blot of HindIII digest of md allelic series probed with cDNA for exons 2-9 shows novel restriction site in md 5J .
kb fragment corresponding to exon 12 in the C3H/HeJ coisogenic homozygous wild-type control and in mahoganoid alleles (md, md 4J , md 5J , md 6J ) (Figure 5b ). The region of probe 2 containing part of exon 12 and its 5′ intronic region was then amplified and sequenced from genomic DNA and demonstrated an approximately 8 kb insertion in exon 12 of md 2J (data not shown). The fragment was shown by sequence analysis to be a retroviral insertion (GenBank numbers AF532997 and AF532998) containing a PstI restriction site ( Figure 6) . md 5J , a 5 kb retroviral insertion in the intron 3′ of exon 2. Southern blot analysis of md 5J DNA restricted with HindIII (but not PstI, EcoRI, BglII, or Sau3AI) and probed with a cDNA corresponding to exons 2-9, demonstrated a different restriction pattern than the C3H/HeJ coisogenic homozygous wild-type control and the other md alleles (Figure 5c ). The md 5J DNA showed loss of an 8.8 kb fragment corresponding to the region of exons 2-4 and introduction of new 5.2 kb and 4.0 kb fragments. Similar results were obtained with a cDNA probe spanning exons 3-5 (data not shown). PCR amplification of genomic md 5J DNA corresponding to the intronic region between exon 2 and exon 3 demonstrated a fragment approximately 5 kb larger than the C3H/HeJ coisogenic homozygous wild-type control (data not shown). Sequence analysis showed that md 5J is a retroviral insertion (GenBank numbers AF532995 and AF532996) of approximately 5 kb in the intronic region 3′ of exon 2 ( Figure 6 ).
md, a 5 kb retroviral insertion in the intron between exons 11-12.
Southern blot analysis of a PstI digest of md using probe 2 demonstrated a missing fragment of 1.1 kb and the presence of a new fragment of 0.6 kb corresponding to the intronic region 5′ of exon 12 ( Figure 5b ). PCR amplification in md genomic DNA of the intron between exons 11 and 12 demonstrated a fragment approximately 5 kb larger than the C3H/HeJ coisogenic +/+, suggesting that the md mutation is due to an insertion in this intron (data not shown). Sequence analysis of the PCR-amplified genomic DNA between exons 11 and 12 showed an inserted retroviral sequence (GenBank number AF532993 and AF532994) within the intron (Figure 6 ).
The insertions are intracisternal type A particle elements.
Comparison of the 5′ and 3′ regions of the insertions detected in md, md 2J , and md 5J with GenBank entries revealed that the insertion is a mouse retrovirus-like repetitive intracisternal type A particle (IAP) element matching GenBank number X04120. The IAP seen in the mahoganoid mutations reported here is similar to the element reported in mahogany (Atrn mg and Atrn mg-L ) (12) . The integrated IAP elements associated with the md mutations were flanked in all instances with canonical long terminal repeat sequences that are frequently observed in contiguous to retroviral IAP insertions (25) .
Expression of mahoganoid alleles. Northern blot analysis, using probe 5 that spans exons 3-13 containing the RING (really interesting new gene) finger domain in exon 10, demonstrated a 3.9 kb mahoganoid transcript expressed in kidney brain, heart, spleen, lung, skin, skeletal muscle, and adipose tissue in B6.V-Lep ob , B6.Cg-A y , and C57BL/6J +/+ mice ( Figure 7a ). An additional transcript of 5.2 kb was also seen in the kidney, brain, and liver; and a transcript of 1.9 kb in the kidney of C57BL/6J +/+, B6.V-Lep ob , and B6.Cg-A y mice ( Figure  7a ). Both were at lower levels of expression than the 3.9 kb transcript. RING finger domain located in exon 10. NCBI Aceview analysis (http:// www.ncbi.nih.gov/IEB/Research/Acem bly/av.cgi?db=29&c=Gene&1=G_tl6_ Hs16_10709_29_1_t16_Hs16_10709_ 29_2_5347) of KIAA0544 showed that the human homologue of md is defined by 139 sequences from 129 cDNA clones and produces, by alternative splicing, six mRNAs of variant a, 4.1 kb; variant b, 3.9 kb; variant c, 5.2 kb; variant d, 1.9 kb; variant e, 2.4 kb; and variant f, 2.2 kb. Using probe 4, which spans exons 3-13, only md transcripts of 3.9 kb, 5.2 kb, and 1.9 kb were detected in Northern blots. These transcripts are similar in size to human transcripts b, c, and d. The human 5.2 kb transcript is alternatively spliced to incorporate an additional 66-bp exon between exons 11 and 12 of the 3.9 transcript as well as to use an alternative splice site for the final exon. Further Blast analysis of md transcript AK011747 in the TIGR Mouse (Mus musculus) gene index (http://www.tigr. org/tigrscripts/tgi/tc_report.pl?species =mouse&tc=TC457132) identified mouse EST TC457132 that corresponds to the human 5.2 kb transcript. An expression profile of KIAA0544 in 14 different tissues (heart, brain, placenta, lung, liver, skeletal muscle, kidney, pancreas, spleen, thymus, prostate, testis, ovary, and small intestine) generated by RT-PCR, indicates that the human homologue has an expression pattern similar to mahoganoid in the mouse (26) .
By quantitative RT-PCR using primers spanning exons 11-12, mahoganoid expression levels relative to actin were found to be similar in the brain and kidney among genetically obese Lep ob / Lep ob and A y /+ mice and C57BL/6J +/+ controls (Table 1) . However, mahoganoid expression in the brain of md/md and md 2J /md 2J animals relative to actin was 5% and 1% of that of C57BL/6J +/+ controls ( Table 1) . The probe spanning exons 11-12 detects both the 3.9 kb and 5.2 kb transcripts. The quantitative RT-PCR results are consistent with the very low expression levels for these transcripts seen in the Northern blots of md and md 2J RNA.
Mahoganoid does not suppress obesity related to a high-fat diet. The dose-dependent effect of md in diminishing the obesity of A y mice is striking and clear (17) . The effect of this mutation on body composition in circumstances in which the gene is not in epistatic apposition to an obesity mutation is reportedly more subtle (17) . We examined this issue by estimating the mouse equivalent of the body mass index (weight in grams/ nasoanal length in square centimeters) (27) in progeny of the N 7 F 14 B6.C3H-md-A md/md x md/+ intercross used for mapping and minimizing the C3H interval containing the md locus. The progeny were fed from the time of weaning at about 21 days with mouse chow containing either 9% or 45% kcal fat. Body weight and nasoanal length were measured every 2 weeks, and the animals were sacrificed at about 115 days when weight and nasoanal length were measured. Body mass index (BMI) was used as a surrogate measure for adiposity (27) . As expected, animals fed 45% kcal as fat were heavier and had higher BMI than those fed 9% fat. However, no effect of md genotype was seen on body weight or BMI of animals fed either the 9% or 45% kcal fat chow (Table 2) . No significant diet-by-genotype interaction was seen for either BMI or body weight as determined by ANOVA (Table 3) . It is important to note that we looked only at md/+ and md/md animals in this analysis because these were the only genotypes issuing from the md/+ × md/md mapping cross.
Absence of a neurological phenotype in md/md mice. Md/md animals are neurologically normal at 15 weeks and at 1 year of age, without obvious tremor or movement disorder. Gross and microscopic examination of the midbrain, cerebellum, pons, hippocampus, hypothalamus, thalamus, cortex, and brainstem demonstrated normal anatomy with no evidence of vacuolization or dysmyelination as is observed in the mahogany mouse (data not shown).
Mahoganoid encodes a 494-amino acid protein containing a C3HC4 RING domain from amino acids 240-278 (Figure 8 ). The human homologue, KIAA0544 (http://www. ncbi.nlm.nih.gov/LocusLink/LocRpt.c gi?l=76564), maps to 16p13.3 and is 81% identical in amino acid sequence. The RING finger domain of KIAA0544 is 99% identical to mahoganoid C3HC4 RING domain. There are homologous genes in Drosophila melanogaster and Caenorhabditis elegans with 43% and 37% identity of amino acids, respectively, that include the highly conserved C3HC4 RING domains (Figure 8 ). 
Discussion
Coat color mutations in mice have provided unique insights into the molecular physiology of melanocortin-related control of coat color and energy homeostasis in mice and other mammals (28) . Remarkably similar (sometimes identical) pathways/molecules are involved in these disparate phenotypes. G protein-coupled melanocortin receptors (MC1R in skin, MC3R and MC4R in brain) mediate the effects of the physiologic ligand, α-MSH, and antagonists, ASP and AgRP (Figure 1 ). Binding of α-MSH to MC1R in the hair follicle, or to MC3R and MC4R in the hypothalamus, increases intracellular cAMP and increases the production of eumelanin in the hair follicle or decreases food intake by effects in the hypothalamus. Conversely, antagonism of MC1R by ASP in the hair follicle, or of MC4R by AgRP in the hypothalamus, produces increased pheomelanin in the hair follicle and increased food intake by effects in the hypothalamus. Constitutive overexpression of ASP in the A y mouse outside of the hair follicle best demonstrates the analogies between the two pathways since the yellow coat color of these mice is due to ASP antagonism of MC1R and the increased weight and adiposity is due to ASP antagonism of MC3R and MC4R in the hypothalamus (28) . Other genes, such as mahogany and mahoganoid, modulate the activity of this pathway in skin and the brain (17) . Here we present evidence that the mahoganoid allelic series is due to mutations in a RING finger protein whose function is unknown but that has a strong impact on the melanocortin signaling. Mutations in the mahoganoid allelic series (md, md 2J , and md 5J ) are due to large retroviral insertions that disrupt the expression of md. Retroviral insertions have been shown to affect gene expression in other coat color mutations such as dilute (29) , agouti (2), and mahogany (10) . Tissue expression data indicate that md is ubiquitously expressed with highest expression in the brain and kidney. Expression of normal mahoganoid transcripts is greatly reduced in md/md and md 2J /md 2J mice in all tissues examined by both Northern blot analysis and quantitative RT-PCR. The ability to identify md was greatly expedited by the availability of near-complete human and mouse genomic sequence and annotation.
Mutations of md in mice act as suppressors of obesity and yellow coat color that are associated with constitutive overexpression of Asp in the A y mouse, but do not alter the yellow coat color phenotype of Mc1r e -deficient mice (extension mutants) (17) . Genetically, mutations in md are epistatic to A y and Mc1r e is epistatic to md, suggesting that mahoganoid is functionally distal to ASP and proximal to MC1R (Figure 1 ). The epistatic relationship appears to be similar in the hair follicle and the hypothalamus since mahoganoid is able to suppress both the yellow coat color phenotype induced by constitutive ASP Expected effects of diet and sex were detected, but no effect of genotype at md or genotype-by-diet interaction was observed. (36). Ubiquitylation has been implicated in the regulation of myriad cellular processes including cell cycling, apoptosis, cellular differentiation, DNA repair, and stress responses. Inherited loss-of-function mutations in other E3 ubiquitin ligase genes have been implicated in juvenile Parkinson disease, Angelman syndrome, breast and ovarian cancer susceptibility (BRCA1), and von Hippel Lindau disease (37) . Ubiquitylation proceeds through a three-step process, involving ubiquitin-activating (E1), ubiquitinconjugating (E2), and ubiquitin-ligating (E3) enzymes. The E3 enzymes mediate the transfer of ubiquitin from the E2 to the substrate and thereby confer substrate specificity (34) .
The mahoganoid protein may decrease signaling through MC1R and MC3R/MC4R by increasing expression or activity of an inverse agonist of MC1R and MC3R/MC4R, influencing the physical proximity or binding of ASP and AgRP to their receptors by influencing binding of ATRN to ASP or by decreasing the amount of α-MSH available to MC1R or MC3R/ MC4R through sequestration or turnover of α-MSH ( Figure 9 ). If mahoganoid is an E3 ligase, identification of the targets of mahoganoid ubiquitylation should define additional components of this system. In this context, it should be noted that knockout mice lacking E3 ubiquitin ligase UBR1 activity have decreased body weight due to reduction in both skeletal muscle and adipose tissues (38) . This phenotype supports a role for the E3 ligase in regulating body mass and composition. The human homologue of mahoganoid maps to 16p13.3. Loci for coronary heart disease, hypertension, and type 2 diabetes have been mapped to this region in Indo-Mauritians and Pondicherian families of Indian origin (39) . These phenotypes could be related to allelic variation in mahoganoid. This possibility can now be tested by mutation analysis and association studies. Molecules that mimic the effects of mahoganoid by suppressing the production or action of its cognate protein might be effective agents in the treatment of obesity.
